<<<<<<< HEAD
ID,Source,Compound,CID,Class,Label,MW,XLOGP,TPSA,H-Bond ACC,H-Bond Donor,Heavy_Atom_Count,Canonical SMILES,Metabolism,Note
3782,Liew,Olsalazine,22419,positive,1,302.24,3.1,140.0,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
3204,Liew,Atenolol,2249,negative,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
456,DILIrank,budesonide,40000,vNo-DILI-Concern,0,430.5,2.5,93.1,6,2,31,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CYP3A4,
679,DILIrank,terazosin,5401,vNo-DILI-Concern,0,387.4,1.4,103.0,8,1,28,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,.,
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
3803,Liew,Oxyphencyclimine,4642,negative,0,344.4,2.9,62.1,4,1,25,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,,
1123,LIverTox,Duloxetine,60835,B,1,297.4,4.3,49.5,3,1,21,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,"Liver, two P450 isozymes, CYP2D6 and CYP1A2",
3668,Liew,Melphalan,460612,positive,1,305.2,-0.5,66.6,4,2,19,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,,
3781,Liew,Olopatadine,5281071,negative,0,337.4,1.5,49.8,4,1,25,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,,
3290,Liew,Cefsulodin,5284530,positive,0,532.6,0.2,225.0,9,3,36,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N,,
3631,Liew,Levamisole,26879,positive,0,204.29,1.8,40.9,2,0,14,C1CSC2=NC(CN21)C3=CC=CC=C3,,
2530,Xu,Benazepril,5362124,Negative,1,424.5,1.3,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Liver glucuronidation,
3308,Liew,Chloroquine,2719,negative,1,319.9,4.6,28.2,3,1,22,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,,
2038,Greene,Demecarium Bromide,5965,HH,1,716.6,,59.1,6,0,42,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-],,
1198,LIverTox,Fidaxomicin,10034073,E,0,1058.0,6.4,267.0,18,7,72,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,.,
2206,Greene,Methapyrilene,4098,HH,1,261.39,2.6,47.6,4,0,18,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2,,
1294,LIverTox,Iloperidone,71360,E,0,426.5,4.1,64.8,7,0,31,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Liver CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation,
3594,Liew,Imiquimod,57469,positive,0,240.3,2.6,56.7,3,1,18,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,,
211,DILIrank,lanthanum carbonate,168924,vNo-DILI-Concern,0,457.84,,190.0,9,0,14,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3],.,
3263,Liew,Carbachol,5831,negative,0,182.65,,52.3,3,1,11,C[N+](C)(C)CCOC(=O)N.[Cl-],,
368,DILIrank,atracurium,47320,vNo-DILI-Concern,0,1243.5,,258.0,18,0,87,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],	Hofmann elimination retro-Michael addition and ester hydrolysis by nonspecific esterases,
116,DILIrank,ergocalciferol,5280793,vNo-DILI-Concern,0,396.6,7.4,20.2,1,1,29,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,.,
349,DILIrank,cosyntropin,16132265,vNo-DILI-Concern,0,4541.0,-19.7,1860.0,68,63,322,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,.,peptide
3376,Liew,Demecarium,5966,negative,0,556.8,6.6,59.1,4,0,40,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C,,
1559,LIverTox,Phenyltoloxamine,7077,E,0,255.35,3.9,12.5,2,0,19,CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2,.,
1369,LIverTox,Lorcaserin,11658860,E,0,195.69,2.7,12.0,1,1,13,CC1CNCCC2=C1C=C(C=C2)Cl,extensive,
3368,Liew,Daptomycin,16129629,positive,1,1620.7,-5.1,702.0,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
4007,Liew,Tenoxicam,5282194,positive,0,337.4,2.2,136.0,8,2,22,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=C(S1(=O)=O)C=CS3,,
1942,Greene,Betaine HCl,247,NE,0,117.15,0.5,40.1,2,0,8,C[N+](C)(C)CC(=O)[O-],,
341,DILIrank,oxytocin,439302,vNo-DILI-Concern,0,1007.2,-2.6,450.0,15,12,69,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,Liver and other oxytocinases,
766,DILIrank,exametazime,9552069,vNo-DILI-Concern,0,742.6,,179.0,12,8,40,CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.[Tc].[Tc],.,
2684,Xu,Isoxsuprine HCl,3783,Negative,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
3149,Liew,Albuterol,2083,negative,0,239.31,0.3,72.7,4,4,17,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,
343,DILIrank,benzphetamine,5311017,vNo-DILI-Concern,0,239.35,4.1,3.2,1,0,18,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,.,
269,DILIrank,zaleplon,5719,vNo-DILI-Concern,0,305.33,1.0,74.3,4,0,23,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,"Liver aldehyde oxidase (91%), CYP3A4 (9%)",
3687,Liew,Methdilazine,14677,positive,0,296.4,5.2,31.8,3,0,21,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,,
3515,Liew,Fluocinonide,9642,negative,0,494.5,3.2,99.1,9,1,35,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,,
1134,LIverTox,Efavirenz,64139,A,1,315.67,4.0,38.3,5,1,21,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,"CYP2A6,CYP2B6",
932,LIverTox,Bisacodyl,2391,E,0,361.4,3.8,65.5,5,0,27,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,CYP450,
2131,Greene,Gentamycin,3467,NE,0,477.6,-4.1,200.0,12,8,33,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,.,
3318,Liew,Ciclesonide,6918155,negative,0,540.7,5.3,99.1,7,1,39,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,,
311,DILIrank,cortisone acetate,5745,vNo-DILI-Concern,0,402.5,2.1,97.7,6,1,29,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,.,
1433,LIverTox,Moexipril,91270,E*,0,498.6,1.2,114.0,8,2,36,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,"active metabolite, moexiprilat",
4079,Liew,Tubocurarine,6000,negative,0,609.7,6.0,80.6,7,2,45,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC,,
3271,Liew,Carteolol,2583,negative,0,292.37,1.0,70.6,4,3,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,,
795,LIverTox,Acrivastine,5284514,E,0,348.4,1.6,53.4,4,1,26,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O,.,
3848,Liew,Pimecrolimus,16051947,negative,0,810.4,3.8,158.0,11,2,56,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CYP3A5,
3737,Liew,Mupirocin,446596,negative,0,500.6,3.0,146.0,9,4,35,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,,
1648,LIverTox,Rifaximin,6436173,E,0,785.9,6.9,198.0,12,5,57,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,Liver,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
3986,Liew,Sulpiride,5355,positive,0,341.4,0.6,110.0,6,2,23,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,,
1925,Greene,Azacytidine,9444,HH,0,244.2,-2.2,141.0,5,4,17,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,.,
3246,Liew,Brimonidine,2435,negative,0,292.13,0.6,62.2,3,2,17,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,,
686,DILIrank,tranylcypromine,19493,vLess-DILI-Concern,1,133.19,1.5,26.0,1,1,10,C1C(C1N)C2=CC=CC=C2,Liver,
3417,Liew,Dipivefrin,3105,negative,0,351.4,2.9,84.9,6,2,25,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C,,
3836,Liew,Phendimetrazine,12460,negative,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
3168,Liew,Amcinonide,443958,negative,0,502.6,3.6,99.1,8,1,36,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6,,
3231,Liew,Benzthiazide,2343,negative,0,431.9,1.7,161.0,7,2,26,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,,
1997,Greene,Chlortetracycline HCl,54675777,HH,1,478.9,-1.3,182.0,9,6,33,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O,.,
2082,Greene,Ergotamine l-Tartrate,8223,NE,0,581.7,2.0,118.0,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C,,
4060,Liew,Trifluridine,6256,negative,0,296.2,-0.5,99.1,8,3,20,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Thymidine phosphorylase,
1929,Greene,Azithromycin,55185,WE,1,749.0,4.0,180.0,14,5,52,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,LIver,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,926.1,-0.2,320.0,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
557,DILIrank,etidronic acid,3305,vNo-DILI-Concern,0,206.03,-3.7,135.0,7,5,11,CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
3958,Liew,Silodosin,5312125,positive,0,495.5,3.6,97.0,9,3,35,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,,
1319,LIverTox,Ivabradine,132999,E,0,468.6,2.4,60.5,6,0,34,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,"Liver first-pass >50%, CYP3A4",
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
1686,LIverTox,Semaglutide,56843331,E,0,4114.0,-5.8,1650.0,63,57,291,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,Proteolysis,
2237,Greene,NaCl,5234,NE,0,58.44,,0.0,1,0,2,[Na+].[Cl-],.,
2755,Xu,Phenacetin,4754,Positive,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
3904,Liew,Quazepam,4999,negative,0,386.8,4.0,47.7,6,0,25,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,Liver,
951,LIverTox,Buprenorphine,644073,B[HD],1,467.6,5.0,62.2,5,2,34,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,"CYP3A4, CYP2C8",
2370,Greene,Phenylpropanolamine HCl,10297,NE,0,151.21,0.8,46.2,2,2,11,CC(C(C1=CC=CC=C1)O)N,CYP2D6,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
1832,LIverTox,Vemurafenib,42611257,E*,0,489.9,5.0,100.0,7,2,33,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,.,
263,DILIrank,maraviroc,3002977,vMost-DILI-Concern,1,513.7,5.1,63.0,6,1,37,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,"Liver CYP, predominantly CYP3A",
323,DILIrank,mecamylamine,4032,vNo-DILI-Concern,0,167.29,2.6,12.0,1,1,12,CC1(C2CCC(C2)C1(C)NC)C,.,
1987,Greene,Cephapirin Sodium,30699,NE,0,423.5,-1.1,177.0,9,2,28,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O,,
3409,Liew,Dihydralazine,10230,positive,0,190.21,0.2,102.0,6,4,14,C1=CC=C2C(=C1)C(=NN=C2NN)NN,,
3811,Liew,Paramethadione,8280,positive,0,157.17,0.8,46.6,3,0,11,CCC1(C(=O)N(C(=O)O1)C)C,,
3393,Liew,Dezocine,3033053,negative,0,245.36,3.7,46.2,2,2,18,CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O,,
2539,Xu,Bumetanide,2471,Positive,1,364.4,2.8,127.0,7,3,25,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,	Liver,
3410,Liew,Dihydroergotamine,10531,negative,0,583.7,2.4,118.0,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,,
3655,Liew,Mafenide,3998,negative,0,186.23,-0.7,94.6,4,2,12,C1=CC(=CC=C1CN)S(=O)(=O)N,,
1523,LIverTox,Panobinostat,6918837,E,0,349.4,3.0,77.2,3,4,26,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,"CYP3A 40%, CYP2D6, CYP2C19",
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
3357,Liew,Cyclothiazide,2910,negative,0,389.9,2.0,135.0,7,3,24,C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl,,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
4041,Liew,Tolazoline,5504,positive,0,160.22,2.6,24.4,1,1,12,C1CN=C(N1)CC2=CC=CC=C2,,
3761,Liew,Nicotine,89594,negative,0,162.23,1.2,16.1,2,0,12,CN1CCCC1C2=CN=CC=C2,,
3583,Liew,Hydroxyurea,3657,positive,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
4012,Liew,Tertatolol,36920,negative,0,295.4,2.7,66.8,4,2,20,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O,,
3574,Liew,Halobetasol,5311167,negative,0,428.9,2.7,74.6,6,2,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,,
1887,Greene,acivicin,294641,NE,0,178.57,-2.7,84.9,5,2,11,C1C(ON=C1Cl)C(C(=O)O)N,.,
1207,LIverTox,Flucytosine,3366,D,1,129.09,-0.9,67.5,3,2,9,C1=NC(=O)NC(=C1F)N,"minimal, in the GI tract",
716,DILIrank,cyanocobalamin,16212801,vNo-DILI-Concern,0,1355.4,,476.0,21,9,93,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],.,
3875,Liew,Prilocaine,4906,negative,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
3217,Liew,Baclofen,2284,positive,1,213.66,-1.0,63.3,3,2,14,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,,
1734,LIverTox,Tacrolimus,445643,C,1,804.0,2.7,178.0,12,3,57,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,"CYP3A4, CYP3A5",
2466,Greene,Trientine HCl,5565,HH,0,146.23,-2.5,76.1,4,4,10,C(CNCCNCCN)N,,
3419,Liew,Dirithromycin,6917067,positive,0,835.1,4.2,196.0,16,5,58,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,,
3496,Liew,Fentanyl,3345,negative,0,336.5,4.0,23.6,2,0,25,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,
3266,Liew,Carboprost,5281075,negative,0,368.5,2.9,98.0,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
3411,Liew,Diltiazem,39186,positive,1,414.5,3.1,84.4,6,0,29,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,
1419,LIverTox,Miglitol,441314,E,0,207.22,-2.6,104.0,6,5,14,C1C(C(C(C(N1CCO)CO)O)O)O,Nil,
3385,Liew,Dexfenfluramine,66265,positive,0,231.26,3.4,12.0,4,1,16,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,,
1251,LIverTox,Glucosamine,439213,D,1,179.17,-2.8,116.0,6,5,12,C(C1C(C(C(C(O1)O)N)O)O)O,.,
3602,Liew,Isoetharine,3762,negative,0,239.31,1.7,72.7,4,4,17,CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C,,
927,LIverTox,Bictegravir,90311989,E*,0,449.4,2.7,99.2,9,2,32,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,.,
1211,LIverTox,Fluoxetine,3386,C,1,309.33,4.0,21.3,5,1,22,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CYP2D6,
2142,Greene,Hycanthone,3634,HH,1,356.5,2.7,77.9,5,2,25,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,,
201,DILIrank,triptorelin pamoate,25074470,vLess-DILI-Concern,0,1311.4,-0.3,490.0,15,17,95,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,.,oligopeptide
1952,Greene,Bromobenzene,7961,HH,1,157.01,3.0,0.0,0,0,7,C1=CC=C(C=C1)Br,.,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2084,Greene,Erythromycin estolate (1),12560,HH,1,733.9,2.7,194.0,14,5,51,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,.,
3590,Liew,Iloprost,5311181,positive,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
3802,Liew,Oxymorphone,5284604,negative,0,301.34,0.8,70.0,5,2,22,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,CYP3A4,
1103,LIverTox,Disopyramide,3114,B,1,339.5,3.2,59.2,3,1,25,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,CYP3A4,
2716,Xu,Methoxamine HCl,6082,Negative,0,211.26,0.5,64.7,4,2,15,CC(C(C1=C(C=CC(=C1)OC)OC)O)N,.,
1907,Greene,ammonium chloride,25517,NE,0,53.49,,1.0,1,1,2,[NH4+].[Cl-],.,
4075,Liew,Tropicamide,5593,negative,0,284.35,1.5,53.4,3,1,21,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,,
2797,Xu,Sorbitol,5780,Negative,0,182.17,-3.1,121.0,6,6,12,C(C(C(C(C(CO)O)O)O)O)O,.,
598,DILIrank,hydroxyzine,3658,vNo-DILI-Concern,0,374.9,3.7,35.9,4,1,26,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Liver,
210,DILIrank,pramlintide,16132446,vNo-DILI-Concern,0,3951.0,-16.7,1690.0,59,58,277,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CS)NC(=O)C(CCCCN)N,Renal,
3276,Liew,Cefamandole,456255,positive,0,462.5,-0.9,201.0,10,3,31,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,,
1677,LIverTox,Saxagliptin,11243969,E*,0,315.4,0.7,90.4,4,2,23,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,"CYP3A4, CYP3A5",
1657,LIverTox,Rivaroxaban,6433119,A,1,435.9,2.5,116.0,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
3617,Liew,Ketorolac,3826,positive,1,255.27,1.9,59.3,3,1,19,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,
3577,Liew,Histrelin,25077993,negative,0,1323.5,0.7,449.0,15,15,96,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
3375,Liew,Delavirdine,5625,positive,0,456.6,2.4,119.0,7,3,32,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,,
1618,LIverTox,Quercetin,5280343,E,0,302.23,1.5,127.0,7,5,22,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,.,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
1011,LIverTox,Cilostazol,2754,E,0,369.5,3.1,81.9,5,1,27,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,"CYP3A4 ,CYP2C19",
3495,Liew,Fenretinide,5288209,positive,0,391.5,7.3,49.3,2,2,29,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,,
2209,Greene,Methotrexate,126941,HH,1,454.4,-1.8,211.0,12,5,33,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,	Liver and intracellular,
1361,LIverTox,Lixisenatide,90472060,E,0,4858.0,-30.8,2090.0,77,70,342,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,.,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
1026,LIverTox,Clonazepam,2802,D,1,315.71,2.4,87.3,4,1,22,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,CYP3A,
3531,Liew,Formestane,11273,negative,0,302.4,2.6,54.4,3,1,22,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,,
1556,LIverTox,Phentermine,4771,E,0,149.23,1.9,26.0,1,1,11,CC(C)(CC1=CC=CC=C1)N,Liver,
3559,Liew,Glutethimide,3487,negative,0,217.26,1.9,46.2,2,1,16,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,
2627,Xu,Diphenhydramine HCl,3100,Negative,0,255.35,3.3,12.5,2,0,19,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,"	CYP2D6, others",
1711,LIverTox,Sotalol,5253,E,0,272.37,0.2,86.8,5,3,18,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Not metabolized,
3755,Liew,Nepafenac,151075,negative,0,254.28,1.9,86.2,3,2,19,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,,
1050,LIverTox,Cyproheptadine,2913,C,1,287.4,4.7,3.2,1,0,22,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CYP3A4,
2236,Greene,N-acetyl cysteine,12035,NE,0,163.2,0.4,67.4,4,3,10,CC(=O)NC(CS)C(=O)O,Liver,
1709,LIverTox,Sonidegib,24775005,E*,0,485.5,5.8,63.7,8,1,35,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,CYP3A,
873,LIverTox,Apremilast,11561674,E,0,460.5,1.8,128.0,7,1,32,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,"CYP3A4, with minor contributions from CYP2A6, CYP1A2",
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
1576,LIverTox,Plicamycin,5284610,A[HD],1,1085.1,0.6,358.0,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
4056,Liew,Trichlormethiazide,5560,negative,0,380.7,0.6,135.0,7,3,20,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,,
1409,LIverTox,Methylphenidate,4158,C[H],1,233.31,0.2,38.3,3,1,17,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Liver 80% mostly CES1A1-mediated,
1037,LIverTox,Colestipol,62816,E,0,281.83,,101.0,6,5,18,C1C(O1)CCl.C(CNCCNCCNCCN)N,.,
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
3742,Liew,Naftifine,47641,negative,0,287.4,5.1,3.2,1,0,22,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32,,
227,DILIrank,doxapram,3156,vNo-DILI-Concern,0,378.5,3.3,32.8,3,0,28,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,.,
466,DILIrank,cefazolin,33255,vLess-DILI-Concern,1,454.5,-0.4,235.0,12,2,29,CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,.,
2172,Greene,Lactose,6134,NE,0,342.3,-4.7,190.0,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
3735,Liew,Moxifloxacin,152946,positive,1,401.4,0.6,82.1,8,2,29,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,,
2537,Xu,Biotin,171548,Negative,0,244.31,0.3,104.0,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
3896,Liew,Propyliodone,4949,negative,0,447.01,2.4,46.6,4,0,16,CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I,,
2090,Greene,ethinyl estradiol,5991,HH,1,296.4,3.7,40.5,2,2,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,	Liver primarily CYP3A4,
267,DILIrank,regadenoson,219024,vNo-DILI-Concern,0,390.35,-1.5,187.0,10,5,28,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,.,
1131,LIverTox,Edaravone,4021,E,0,174.2,1.3,32.7,2,0,13,CC1=NN(C(=O)C1)C2=CC=CC=C2,.,
1452,LIverTox,Naloxegol,56959087,E,0,651.8,-1.0,127.0,12,2,46,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,CYP3A,
3553,Liew,Gefitinib,123631,positive,1,446.9,4.1,68.7,8,1,31,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,,
511,DILIrank,paliperidone,115237,vNo-DILI-Concern,0,426.5,2.2,82.2,7,1,31,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,.,
3337,Liew,Clofibrate,2796,positive,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
3555,Liew,Gemfibrozil,3463,positive,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
1430,LIverTox,Mitotane,4211,E*,0,320.0,6.2,0.0,0,0,18,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,.,
3062,Liew,Pemetrexed,135410875,positive,1,427.4,0.2,187.0,7,6,31,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,,
1852,LIverTox,Vortioxetine,9966051,E*,0,298.4,4.2,40.6,3,1,21,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,"Liver, primarily CYP2D6-mediated oxidation",
2528,Xu,Bambuterol,54766,Negative,0,367.4,1.2,91.3,6,2,26,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,Extensive Liver.Further metabolized to terbutaline by plasma cholinesterase,
785,LIverTox,Abemaciclib,46220502,E*,0,506.6,3.8,75.0,9,1,37,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,.,
1341,LIverTox,Larotrectinib,46188928,E*,0,428.4,1.7,86.0,7,2,31,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,.,
18,DILIrank,tetracycline,54685734,vLess-DILI-Concern,1,444.4,-2.0,182.0,9,6,32,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,Not metabolized,
3198,Liew,Aprindine,2218,positive,0,322.5,5.2,6.5,2,0,24,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3,,
1343,LIverTox,Lefamulin,25185057,E,0,507.7,4.3,135.0,7,3,35,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,.,
636,DILIrank,nilutamide,4493,vMost-DILI-Concern,1,317.22,2.0,95.2,7,1,22,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,"Liver CYP2C19, FMOTooltip flavin-containing monooxygenase",
1224,LIverTox,Fosphenytoin,56339,A,1,362.27,0.6,116.0,6,3,25,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Liver,
3328,Liew,Clarithromycin,84029,positive,1,748.0,3.2,183.0,14,4,52,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,,
2410,Greene,Ribavirin,37542,E*,0,244.2,-1.8,144.0,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
1022,LIverTox,Clofazimine,2794,E,0,473.4,7.1,40.0,4,1,33,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,.,
3909,Liew,Quinethazone,6307,positive,0,289.74,1.2,110.0,5,3,18,CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl,,
1563,LIverTox,Pimavanserin,10071196,E,0,427.6,4.5,44.8,4,1,31,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,"CYP3A4, CYP3A5, CYP2J2",
1936,Greene,Beclomethasone Dipropionate,21700,NE,0,521.0,3.0,107.0,7,1,36,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,	By esterase enzymes found in most tissues,
272,DILIrank,etravirine,193962,vMost-DILI-Concern,1,435.3,4.5,121.0,7,2,28,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,"CYP3A4,CYP2C9,CYP2C19",
1545,LIverTox,Peramivir,151164,E,0,328.41,0.0,151.0,5,5,23,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,.,
3169,Liew,Amdinocillin,36273,positive,0,325.4,2.1,98.5,5,1,22,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,,
4024,Liew,Thiopental,3000714,positive,0,264.32,,96.6,3,1,17,CCCC(C)C1(C(=O)NC(=S)N=C1[O-])CC.[Na+],Liver,
3436,Liew,Droloxifene,3033767,positive,0,387.5,6.8,32.7,3,1,29,CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3,,
958,LIverTox,Cabazitaxel,9854073,E*,0,835.9,2.7,202.0,14,3,60,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,.,
3366,Liew,Dapiprazole,3033538,negative,0,325.5,2.4,37.2,4,0,24,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,,
60,DILIrank,labetalol,3869,vMost-DILI-Concern,1,328.4,3.1,95.6,4,4,24,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,"Liver pass metabolism,",
3378,Liew,Deserpidine,8550,negative,0,578.7,4.1,109.0,9,1,42,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,,
1353,LIverTox,Levofloxacin,149096,A,1,361.4,-0.4,73.3,8,1,26,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,<5% desmethyl and N-oxide metabolites,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
4080,Liew,Unoprostone,5311236,negative,0,382.5,3.7,94.8,5,3,27,CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O,,
3458,Liew,Erlotinib,176870,positive,1,393.4,3.3,74.7,7,1,29,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,,
3645,Liew,Lonidamine,39562,positive,0,321.2,4.3,55.1,3,1,21,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,,
2261,Greene,Orphenadrine Citrate,4601,NE,0,269.4,3.8,12.5,2,0,20,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,	Liver demethylation,
171,DILIrank,protirelin,638678,vNo-DILI-Concern,0,362.38,-2.5,150.0,5,4,26,C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N,.,
1034,LIverTox,Codeine,5284371,E,0,299.4,1.1,41.9,4,1,22,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,"Liver: CYP2D6 to morphine, CYP3A4 to norcodeine, UGT2B7 to 3- and 6-glucuronides of codeine, norcodeine, and morphine",
1581,LIverTox,Pramipexole,119570,E,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,227.09,1.6,165.0,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
213,DILIrank,albendazole,2082,vMost-DILI-Concern,1,265.33,2.9,92.3,4,2,18,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Liver,
1685,LIverTox,Selexipag,9913767,E,0,496.6,3.8,110.0,7,1,35,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,"Activation by carboxylesterases, inactivation by CYP2C8 and others",
3287,Liew,Cefotiam,43708,positive,1,525.6,-2.4,251.0,13,3,34,CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O,,
3954,Liew,Sertaconazole,65863,positive,0,437.8,6.3,55.3,3,0,27,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,,
3394,Liew,Diacerein,26248,positive,1,368.3,1.9,124.0,8,1,27,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
3650,Liew,Loteprednol,444025,negative,0,466.9,3.9,99.1,7,1,32,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,,
3125,Liew,Valganciclovir,135413535,negative,1,354.36,-1.5,167.0,8,4,25,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,,
3785,Liew,Opipramol,9417,positive,1,363.5,3.6,30.0,4,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,CYP2D6,
2180,Greene,Lidocaine,3676,NE,0,234.34,2.3,32.3,2,1,17,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,"	Liver, 90% CYP3A4",
2507,Xu,Amantadine HCl,64150,Negative,0,187.71,,26.0,1,2,12,C1C2CC3CC1CC(C2)(C3)N.Cl,	Minimal mostly to acetyl metabolites,
3468,Liew,Eszopiclone,969472,negative,0,388.8,0.5,91.8,7,0,27,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,
3382,Liew,Desonide,12536,negative,0,416.5,2.7,93.1,6,2,30,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,,
3857,Liew,Pirbuterol,4845,negative,0,240.3,-0.1,85.6,5,4,17,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,,
3867,Liew,Prajmaline,37042,positive,0,369.5,2.7,43.7,3,2,27,CCC[N+]12C3CC(C(C1O)CC)C4C2CC5(C3N(C6=CC=CC=C65)C)C4O,,
3402,Liew,Diethylpropion,7029,negative,0,205.3,2.8,20.3,2,0,15,CCN(CC)C(C)C(=O)C1=CC=CC=C1,,
1014,LIverTox,Cisplatin,2767,C,1,298.03,,2.0,2,2,5,[NH2-].[NH2-].Cl[Pt+2]Cl,.,
3480,Liew,Etonogestrel,21729469,positive,0,324.5,3.3,37.3,2,1,24,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,,
3511,Liew,Flumethasone,16490,negative,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
760,DILIrank,apomorphine,6005,vNo-DILI-Concern,0,267.32,2.3,43.7,3,2,20,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,"Liver, phase II",
2072,Greene,Dopamine,681,NE,0,153.18,-1.0,66.5,3,3,11,C1=CC(=C(C=C1CCN)O)O,"MAO, COMT",
3980,Liew,Sulfamethizole,5328,positive,1,270.3,0.5,135.0,7,2,17,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,
217,DILIrank,atropine,174174,vNo-DILI-Concern,0,289.4,1.8,49.8,4,1,21,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,???50% hydrolysed to tropine and tropic acid,
2164,Greene,Isoxicam,54677972,NE,0,335.34,3.0,121.0,7,2,23,CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,.,
3288,Liew,Cefpirome,6917674,positive,0,514.6,0.9,208.0,10,2,35,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],,
56,DILIrank,imatinib,5291,vMost-DILI-Concern,1,493.6,3.5,86.3,7,2,37,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,
3823,Liew,Penicillin v,6869,positive,0,350.4,2.1,121.0,6,2,24,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,,
3518,Liew,Fluorometholone,9878,negative,0,376.5,2.0,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
765,DILIrank,norethindrone acetate,5832,vNo-DILI-Concern,0,340.5,3.5,43.4,3,0,25,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,.,
3270,Liew,Carprofen,2581,positive,1,273.71,4.0,53.1,2,2,19,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,,
3510,Liew,Flumequine,3374,positive,1,261.25,2.9,57.6,5,1,19,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,,
1773,LIverTox,Ticarcillin,36921,D,1,384.4,0.8,178.0,8,3,25,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,.,
3852,Liew,Pipecuronium,65332,negative,0,762.7,,59.1,8,0,45,CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-],,
497,DILIrank,clometacin,33176,vMost-DILI-Concern,1,357.8,4.0,68.5,4,1,25,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,.,
3634,Liew,Levocabastine,54385,negative,0,420.5,2.5,64.3,5,1,31,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,,
3333,Liew,Clobetasol,5311051,negative,0,410.9,2.5,74.6,5,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,,
2665,Xu,Gallamine Triethiodide,6172,Negative,0,891.5,,27.7,6,0,39,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],.,
3147,Liew,Alacepril,71992,positive,0,406.5,2.1,129.0,6,2,28,CC(CSC(=O)C)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O,,
3669,Liew,Memantine,4054,positive,1,179.3,3.3,26.0,1,1,13,CC12CC3CC(C1)(CC(C3)(C2)N)C,,
3476,Liew,Etidocaine,37497,negative,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
3868,Liew,Pranlukast,4887,positive,0,481.5,4.2,119.0,7,2,36,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,CYP3A4,
3939,Liew,Rofecoxib,5090,positive,1,314.4,2.3,68.8,4,0,22,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Liver,
4061,Liew,Trihexyphenidyl,5572,negative,0,301.5,4.5,23.5,2,1,22,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,,
1661,LIverTox,Rolapitant,10311306,E,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
3913,Liew,Raltitrexed,104758,positive,0,458.5,1.4,177.0,8,4,32,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,,
3194,Liew,Anisotropine,6647,negative,0,362.3,,26.3,3,0,21,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],,
3880,Liew,Procainamide,4913,positive,1,235.33,0.9,58.4,3,2,17,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,CYP2D6,
3812,Liew,Paromomycin,441375,negative,1,713.7,,430.0,23,15,47,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,
2240,Greene,Nalidixic Acid,4421,HH,1,232.23,1.4,70.5,5,1,17,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,	Partially Liver,
147,DILIrank,benzbromarone,2333,vMost-DILI-Concern,1,424.1,5.7,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,.,
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
461,DILIrank,adefovir,60172,vLess-DILI-Concern,0,273.19,-2.0,136.0,8,3,18,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,.,
2822,Xu,Trimethadione,5576,Positive,1,143.14,0.3,46.6,3,0,10,CC1(C(=O)N(C(=O)O1)C)C,	Demethylated to dimethadione,
3280,Liew,Cefmenoxime,9570757,positive,0,511.6,0.0,270.0,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
3310,Liew,Chloroxine,2722,negative,0,214.04,3.5,33.1,2,1,13,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,,
4065,Liew,Trimethobenzamide,5577,positive,1,388.5,2.3,69.3,6,1,28,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,
2625,Xu,Digoxin,2724385,Negative,0,780.9,1.3,203.0,14,6,55,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Liver 16%,
1577,LIverTox,Pomalidomide,134780,D,1,273.24,0.2,110.0,5,2,20,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Liver mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6,
2832,Xu,Vidarabine,21704,Negative,0,267.24,-1.1,140.0,8,4,19,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
1573,LIverTox,Plazomicin,42613186,E,0,592.7,-6.2,269.0,15,11,41,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,.,
3387,Liew,Dexlansoprazole,9578005,positive,1,369.4,2.8,87.1,8,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,,
140,DILIrank,primidone,4909,vNo-DILI-Concern,0,218.25,0.9,58.2,2,2,16,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Liver,
452,DILIrank,gadobenate dimeglumine,105124,vNo-DILI-Concern,0,667.7,,220.0,14,2,37,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],.,
278,DILIrank,prasugrel hydrochloride,6918456,vLess-DILI-Concern,1,373.4,3.6,74.8,6,0,26,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,.,
959,LIverTox,Cabozantinib,25102847,E*,0,501.5,5.4,98.8,7,2,37,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,CYP3A4,
1851,LIverTox,Vorinostat,5311,E,0,264.32,1.9,78.4,3,3,19,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Liver glucuronidation and ??-oxidation
CYP system not involved",
1732,LIverTox,Suvorexant,24965990,E,0,450.9,4.9,80.3,6,0,32,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,"Liver CYP3A major, CYP2C19 minor",
2677,Xu,Idarubicin HCl,42890,Negative,0,497.5,1.9,177.0,10,5,36,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,
3166,Liew,Ambenonium,2131,negative,0,537.6,5.1,58.2,2,2,36,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,,
1367,LIverTox,Loratadine,3957,E*,0,382.9,5.2,42.4,3,0,27,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,"CYP2D6, CYP3A4",
902,LIverTox,Baloxavir,124081896,E,0,571.6,3.8,123.0,12,0,40,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,.,
3483,Liew,Etretinate,5282375,positive,0,354.5,6.8,35.5,3,0,26,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,,
922,LIverTox,Betrixaban,10275777,E*,0,451.9,3.6,107.0,5,3,32,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,.,
3512,Liew,Flunarizine,941361,negative,0,404.5,6.0,6.5,4,0,30,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
1185,LIverTox,Ezogabine,121892,E,0,303.33,2.8,76.4,5,3,22,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,Liver glucuronidation and acetylation. CYP not involved,
3756,Liew,Netilmicin,41859,positive,0,475.6,-4.2,200.0,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
3485,Liew,Exisulind,5472495,positive,0,372.4,3.5,79.8,5,1,26,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,,
956,LIverTox,Butorphanol,5361092,ND,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
1435,LIverTox,Molindone,23897,D,1,276.37,1.7,45.3,3,1,20,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Liver,
3192,Liew,Aniracetam,2196,negative,0,219.24,1.6,46.6,3,0,16,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,,
3218,Liew,Balsalazide,5362070,negative,0,357.32,1.2,145.0,8,4,26,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,,
1428,LIverTox,Mirtazapine,4205,C,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
3487,Liew,Famciclovir,3324,positive,0,321.33,0.0,122.0,8,1,23,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,,
2764,Xu,Pinacidil,4826,Negative,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
836,LIverTox,Ampicillin,6249,C,1,349.4,-1.1,138.0,6,3,24,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,12 to 50%,
3888,Liew,Promethazine,4927,positive,0,284.4,4.8,31.8,3,0,20,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Liver,
2243,Greene,naproxen,156391,WE,1,230.26,3.3,46.5,3,1,17,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,	Liver to 6-desmethylnaproxen,
3273,Liew,Caspofungin,468682,positive,1,1093.3,0.3,412.0,18,16,77,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,,
291,DILIrank,alclofenac,30951,vMost-DILI-Concern,1,226.65,2.5,46.5,3,1,15,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,.,
4001,Liew,Temocillin,171758,negative,0,414.5,1.1,187.0,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,581.6,-8.0,336.0,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
3526,Liew,Fluticasone,5311101,negative,0,444.5,3.2,99.9,8,2,30,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,,
606,DILIrank,l-carnitine,288,vNo-DILI-Concern,0,161.2,-0.2,60.4,3,1,11,C[N+](C)(C)CC(CC(=O)[O-])O,slightly,
3841,Liew,Phenoxybenzamine,4768,negative,0,303.8,4.4,12.5,2,0,21,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,,
1290,LIverTox,Ibrutinib,24821094,D,1,440.5,3.6,99.2,6,1,33,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,"CYP3A,CYP2D6",
1509,LIverTox,Osimertinib,71496458,E*,0,499.6,3.7,87.6,7,2,37,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,Oxidation CYP3A,
1557,LIverTox,Phentermine-Topiramate,56842108,E*,0,488.6,,150.0,10,2,33,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N,.,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
1527,LIverTox,Pasireotide,9941444,E*,0,1047.2,4.7,281.0,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
601,DILIrank,l-methionine,6137,vNo-DILI-Concern,0,149.21,-1.9,88.6,4,2,9,CSCCC(C(=O)O)N,.,
4017,Liew,Tetrahydrozoline,5419,negative,0,200.28,1.8,24.4,1,1,15,C1CC(C2=CC=CC=C2C1)C3=NCCN3,,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
574,DILIrank,fludarabine,657237,vNo-DILI-Concern,0,285.23,-0.6,140.0,9,4,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,.,
1707,LIverTox,Sofosbuvir,45375808,A,1,529.5,1.0,153.0,11,3,36,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,"Quickly activated to triphosphate CatA/CES1, HIST1, phosphorylation",
107,DILIrank,prednisone,5865,vLess-DILI-Concern,1,358.4,1.5,91.7,5,2,26,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,prednisolone liver,
3629,Liew,Letrozole,3902,positive,1,285.3,2.7,78.3,4,0,22,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,,
3842,Liew,Phenprocoumon,9908,negative,0,280.3,3.6,46.5,3,1,21,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,"CYP2C9, CYP3A4",
1712,LIverTox,Spironolactone,5833,D,1,416.6,2.9,85.7,5,0,29,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,"Liver, others: Deacetylation via CESTooltip carboxylesterase  S-Oxygenation via FOMTooltip flavin-containing monooxygenase S-Methylation via TMTTooltip thiol S-methyltransferase Dethioacetylation Hydroxylation via CYP3A4  Lactone hydrolysis via PON3",
2057,Greene,Dimercaprol,3080,HH,0,124.23,0.2,22.2,3,3,6,C(C(CS)S)O,,
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
3733,Liew,Morniflumate,72106,negative,0,395.4,3.7,63.7,9,1,28,C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F,,
2750,Xu,Paroxetine,43815,Negative,1,329.4,3.5,39.7,5,1,24,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,"Extensive, liver mostly CYP2D6-mediated",
897,LIverTox,Azilsartan,135415867,E*,1,456.4,4.4,115.0,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
4022,Liew,Thiethylperazine,5440,positive,0,399.6,5.4,60.3,5,0,27,CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C,,
657,DILIrank,pimozide,16362,vNo-DILI-Concern,0,461.5,6.3,35.6,4,1,34,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,"CYP3A4, CYP1A2,CYP2D6",
118,DILIrank,isoproterenol,3779,vNo-DILI-Concern,0,211.26,-0.6,72.7,4,4,15,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,.,
3470,Liew,Ethacrynic acid,3278,positive,1,303.13,3.8,63.6,4,1,19,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,,
3434,Liew,Doxycycline,54671203,positive,1,444.4,-0.7,182.0,9,6,32,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,,
380,DILIrank,calcium acetate,6116,vNo-DILI-Concern,0,158.17,,80.3,4,0,9,CC(=O)[O-].CC(=O)[O-].[Ca+2],.,
3825,Liew,Pentazocine,441278,negative,0,285.4,3.3,23.5,2,1,21,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,Liver,
1299,LIverTox,Indinavir,5362440,C,1,613.8,2.8,118.0,7,4,45,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,CYP3A4,
1749,LIverTox,Temazepam,5391,E,0,300.74,2.2,52.9,3,1,21,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Liver,
3138,Liew,Acemetacin,1981,positive,0,415.8,4.2,94.8,6,1,29,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,,
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
3191,Liew,Anastrozole,2187,positive,1,293.4,2.1,78.3,4,0,22,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,
3235,Liew,Bethanidine,2368,negative,0,177.25,0.9,36.4,1,2,13,CNC(=NC)NCC1=CC=CC=C1,,
3760,Liew,Niclosamide,4477,negative,0,327.12,4.0,95.2,4,2,21,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,
1378,LIverTox,Macitentan,16004692,E*,0,588.3,3.7,137.0,10,2,32,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,"Hydrolysis, oxidation CYP3A4",
1113,LIverTox,Doxazosin,3157,E*,0,451.5,2.5,112.0,9,1,33,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Liver,
3750,Liew,Nedocromil,50294,negative,0,371.3,2.2,121.0,8,2,27,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,,
3517,Liew,Fluoroacetic acid,5237,positive,0,78.04,0.2,37.3,3,1,5,C(C(=O)O)F,,
2718,Xu,Methysergide Maleate,9681,Negative,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
3101,Liew,Teriparatide,16132393,negative,0,4118.0,-18.7,1800.0,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
1221,LIverTox,Foscarnet,3415,D,1,126.01,-2.0,94.8,5,3,7,C(=O)(O)P(=O)(O)O,.,
3210,Liew,Azatadine,19861,negative,0,290.4,3.6,16.1,2,0,22,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1,,
3472,Liew,Ethchlorvynol,5281077,positive,0,144.6,1.5,20.2,1,1,9,CCC(C=CCl)(C#C)O,,
132,DILIrank,glipizide,3478,vLess-DILI-Concern,1,445.5,1.9,139.0,6,3,31,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Liver hydroxylation,
3414,Liew,Dinoprostone,5280360,positive,0,352.5,2.8,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,,
424,DILIrank,almotriptan,123606,vNo-DILI-Concern,0,335.5,1.6,64.8,4,1,23,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,	Liver,
4084,Liew,Valrubicin,454216,negative,0,723.6,4.0,215.0,16,5,51,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,
3600,Liew,Isepamicin,3037209,positive,0,569.6,-6.9,298.0,16,12,39,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O,,
489,DILIrank,conivaptan,151171,vNo-DILI-Concern,0,498.6,5.7,78.1,3,2,38,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,.,
3887,Liew,Promazine,4926,positive,0,284.4,4.5,31.8,3,0,20,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,,
3224,Liew,Benoxinate,4633,negative,0,308.4,3.1,64.8,5,1,22,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,,
=======
ID,Source,Compound,CID,Class,Label,MW,XLOGP,TPSA,H-Bond ACC,H-Bond Donor,Heavy_Atom_Count,Canonical SMILES,Metabolism,Note
3782,Liew,Olsalazine,22419,positive,1,302.24,3.1,140.0,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
3204,Liew,Atenolol,2249,negative,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
456,DILIrank,budesonide,40000,vNo-DILI-Concern,0,430.5,2.5,93.1,6,2,31,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CYP3A4,
679,DILIrank,terazosin,5401,vNo-DILI-Concern,0,387.4,1.4,103.0,8,1,28,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,.,
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
3803,Liew,Oxyphencyclimine,4642,negative,0,344.4,2.9,62.1,4,1,25,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,,
1123,LIverTox,Duloxetine,60835,B,1,297.4,4.3,49.5,3,1,21,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,"Liver, two P450 isozymes, CYP2D6 and CYP1A2",
3668,Liew,Melphalan,460612,positive,1,305.2,-0.5,66.6,4,2,19,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,,
3781,Liew,Olopatadine,5281071,negative,0,337.4,1.5,49.8,4,1,25,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,,
3290,Liew,Cefsulodin,5284530,positive,0,532.6,0.2,225.0,9,3,36,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N,,
3631,Liew,Levamisole,26879,positive,0,204.29,1.8,40.9,2,0,14,C1CSC2=NC(CN21)C3=CC=CC=C3,,
2530,Xu,Benazepril,5362124,Negative,1,424.5,1.3,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Liver glucuronidation,
3308,Liew,Chloroquine,2719,negative,1,319.9,4.6,28.2,3,1,22,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,,
2038,Greene,Demecarium Bromide,5965,HH,1,716.6,,59.1,6,0,42,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-],,
1198,LIverTox,Fidaxomicin,10034073,E,0,1058.0,6.4,267.0,18,7,72,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,.,
2206,Greene,Methapyrilene,4098,HH,1,261.39,2.6,47.6,4,0,18,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2,,
1294,LIverTox,Iloperidone,71360,E,0,426.5,4.1,64.8,7,0,31,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Liver CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation,
3594,Liew,Imiquimod,57469,positive,0,240.3,2.6,56.7,3,1,18,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,,
211,DILIrank,lanthanum carbonate,168924,vNo-DILI-Concern,0,457.84,,190.0,9,0,14,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3],.,
3263,Liew,Carbachol,5831,negative,0,182.65,,52.3,3,1,11,C[N+](C)(C)CCOC(=O)N.[Cl-],,
368,DILIrank,atracurium,47320,vNo-DILI-Concern,0,1243.5,,258.0,18,0,87,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],	Hofmann elimination retro-Michael addition and ester hydrolysis by nonspecific esterases,
116,DILIrank,ergocalciferol,5280793,vNo-DILI-Concern,0,396.6,7.4,20.2,1,1,29,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,.,
349,DILIrank,cosyntropin,16132265,vNo-DILI-Concern,0,4541.0,-19.7,1860.0,68,63,322,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,.,peptide
3376,Liew,Demecarium,5966,negative,0,556.8,6.6,59.1,4,0,40,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C,,
1559,LIverTox,Phenyltoloxamine,7077,E,0,255.35,3.9,12.5,2,0,19,CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2,.,
1369,LIverTox,Lorcaserin,11658860,E,0,195.69,2.7,12.0,1,1,13,CC1CNCCC2=C1C=C(C=C2)Cl,extensive,
3368,Liew,Daptomycin,16129629,positive,1,1620.7,-5.1,702.0,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
4007,Liew,Tenoxicam,5282194,positive,0,337.4,2.2,136.0,8,2,22,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=C(S1(=O)=O)C=CS3,,
1942,Greene,Betaine HCl,247,NE,0,117.15,0.5,40.1,2,0,8,C[N+](C)(C)CC(=O)[O-],,
341,DILIrank,oxytocin,439302,vNo-DILI-Concern,0,1007.2,-2.6,450.0,15,12,69,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,Liver and other oxytocinases,
766,DILIrank,exametazime,9552069,vNo-DILI-Concern,0,742.6,,179.0,12,8,40,CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.[Tc].[Tc],.,
2684,Xu,Isoxsuprine HCl,3783,Negative,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
3149,Liew,Albuterol,2083,negative,0,239.31,0.3,72.7,4,4,17,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,
343,DILIrank,benzphetamine,5311017,vNo-DILI-Concern,0,239.35,4.1,3.2,1,0,18,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,.,
269,DILIrank,zaleplon,5719,vNo-DILI-Concern,0,305.33,1.0,74.3,4,0,23,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,"Liver aldehyde oxidase (91%), CYP3A4 (9%)",
3687,Liew,Methdilazine,14677,positive,0,296.4,5.2,31.8,3,0,21,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,,
3515,Liew,Fluocinonide,9642,negative,0,494.5,3.2,99.1,9,1,35,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,,
1134,LIverTox,Efavirenz,64139,A,1,315.67,4.0,38.3,5,1,21,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,"CYP2A6,CYP2B6",
932,LIverTox,Bisacodyl,2391,E,0,361.4,3.8,65.5,5,0,27,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,CYP450,
2131,Greene,Gentamycin,3467,NE,0,477.6,-4.1,200.0,12,8,33,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,.,
3318,Liew,Ciclesonide,6918155,negative,0,540.7,5.3,99.1,7,1,39,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,,
311,DILIrank,cortisone acetate,5745,vNo-DILI-Concern,0,402.5,2.1,97.7,6,1,29,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,.,
1433,LIverTox,Moexipril,91270,E*,0,498.6,1.2,114.0,8,2,36,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,"active metabolite, moexiprilat",
4079,Liew,Tubocurarine,6000,negative,0,609.7,6.0,80.6,7,2,45,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC,,
3271,Liew,Carteolol,2583,negative,0,292.37,1.0,70.6,4,3,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,,
795,LIverTox,Acrivastine,5284514,E,0,348.4,1.6,53.4,4,1,26,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O,.,
3848,Liew,Pimecrolimus,16051947,negative,0,810.4,3.8,158.0,11,2,56,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CYP3A5,
3737,Liew,Mupirocin,446596,negative,0,500.6,3.0,146.0,9,4,35,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,,
1648,LIverTox,Rifaximin,6436173,E,0,785.9,6.9,198.0,12,5,57,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,Liver,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
3986,Liew,Sulpiride,5355,positive,0,341.4,0.6,110.0,6,2,23,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,,
1925,Greene,Azacytidine,9444,HH,0,244.2,-2.2,141.0,5,4,17,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,.,
3246,Liew,Brimonidine,2435,negative,0,292.13,0.6,62.2,3,2,17,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,,
686,DILIrank,tranylcypromine,19493,vLess-DILI-Concern,1,133.19,1.5,26.0,1,1,10,C1C(C1N)C2=CC=CC=C2,Liver,
3417,Liew,Dipivefrin,3105,negative,0,351.4,2.9,84.9,6,2,25,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C,,
3836,Liew,Phendimetrazine,12460,negative,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
3168,Liew,Amcinonide,443958,negative,0,502.6,3.6,99.1,8,1,36,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6,,
3231,Liew,Benzthiazide,2343,negative,0,431.9,1.7,161.0,7,2,26,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,,
1997,Greene,Chlortetracycline HCl,54675777,HH,1,478.9,-1.3,182.0,9,6,33,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O,.,
2082,Greene,Ergotamine l-Tartrate,8223,NE,0,581.7,2.0,118.0,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C,,
4060,Liew,Trifluridine,6256,negative,0,296.2,-0.5,99.1,8,3,20,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Thymidine phosphorylase,
1929,Greene,Azithromycin,55185,WE,1,749.0,4.0,180.0,14,5,52,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,LIver,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,926.1,-0.2,320.0,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
557,DILIrank,etidronic acid,3305,vNo-DILI-Concern,0,206.03,-3.7,135.0,7,5,11,CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
3958,Liew,Silodosin,5312125,positive,0,495.5,3.6,97.0,9,3,35,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,,
1319,LIverTox,Ivabradine,132999,E,0,468.6,2.4,60.5,6,0,34,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,"Liver first-pass >50%, CYP3A4",
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
1686,LIverTox,Semaglutide,56843331,E,0,4114.0,-5.8,1650.0,63,57,291,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,Proteolysis,
2237,Greene,NaCl,5234,NE,0,58.44,,0.0,1,0,2,[Na+].[Cl-],.,
2755,Xu,Phenacetin,4754,Positive,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
3904,Liew,Quazepam,4999,negative,0,386.8,4.0,47.7,6,0,25,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,Liver,
951,LIverTox,Buprenorphine,644073,B[HD],1,467.6,5.0,62.2,5,2,34,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,"CYP3A4, CYP2C8",
2370,Greene,Phenylpropanolamine HCl,10297,NE,0,151.21,0.8,46.2,2,2,11,CC(C(C1=CC=CC=C1)O)N,CYP2D6,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
1832,LIverTox,Vemurafenib,42611257,E*,0,489.9,5.0,100.0,7,2,33,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,.,
263,DILIrank,maraviroc,3002977,vMost-DILI-Concern,1,513.7,5.1,63.0,6,1,37,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,"Liver CYP, predominantly CYP3A",
323,DILIrank,mecamylamine,4032,vNo-DILI-Concern,0,167.29,2.6,12.0,1,1,12,CC1(C2CCC(C2)C1(C)NC)C,.,
1987,Greene,Cephapirin Sodium,30699,NE,0,423.5,-1.1,177.0,9,2,28,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O,,
3409,Liew,Dihydralazine,10230,positive,0,190.21,0.2,102.0,6,4,14,C1=CC=C2C(=C1)C(=NN=C2NN)NN,,
3811,Liew,Paramethadione,8280,positive,0,157.17,0.8,46.6,3,0,11,CCC1(C(=O)N(C(=O)O1)C)C,,
3393,Liew,Dezocine,3033053,negative,0,245.36,3.7,46.2,2,2,18,CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O,,
2539,Xu,Bumetanide,2471,Positive,1,364.4,2.8,127.0,7,3,25,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,	Liver,
3410,Liew,Dihydroergotamine,10531,negative,0,583.7,2.4,118.0,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,,
3655,Liew,Mafenide,3998,negative,0,186.23,-0.7,94.6,4,2,12,C1=CC(=CC=C1CN)S(=O)(=O)N,,
1523,LIverTox,Panobinostat,6918837,E,0,349.4,3.0,77.2,3,4,26,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,"CYP3A 40%, CYP2D6, CYP2C19",
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
3357,Liew,Cyclothiazide,2910,negative,0,389.9,2.0,135.0,7,3,24,C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl,,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
4041,Liew,Tolazoline,5504,positive,0,160.22,2.6,24.4,1,1,12,C1CN=C(N1)CC2=CC=CC=C2,,
3761,Liew,Nicotine,89594,negative,0,162.23,1.2,16.1,2,0,12,CN1CCCC1C2=CN=CC=C2,,
3583,Liew,Hydroxyurea,3657,positive,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
4012,Liew,Tertatolol,36920,negative,0,295.4,2.7,66.8,4,2,20,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O,,
3574,Liew,Halobetasol,5311167,negative,0,428.9,2.7,74.6,6,2,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,,
1887,Greene,acivicin,294641,NE,0,178.57,-2.7,84.9,5,2,11,C1C(ON=C1Cl)C(C(=O)O)N,.,
1207,LIverTox,Flucytosine,3366,D,1,129.09,-0.9,67.5,3,2,9,C1=NC(=O)NC(=C1F)N,"minimal, in the GI tract",
716,DILIrank,cyanocobalamin,16212801,vNo-DILI-Concern,0,1355.4,,476.0,21,9,93,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],.,
3875,Liew,Prilocaine,4906,negative,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
3217,Liew,Baclofen,2284,positive,1,213.66,-1.0,63.3,3,2,14,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,,
1734,LIverTox,Tacrolimus,445643,C,1,804.0,2.7,178.0,12,3,57,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,"CYP3A4, CYP3A5",
2466,Greene,Trientine HCl,5565,HH,0,146.23,-2.5,76.1,4,4,10,C(CNCCNCCN)N,,
3419,Liew,Dirithromycin,6917067,positive,0,835.1,4.2,196.0,16,5,58,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,,
3496,Liew,Fentanyl,3345,negative,0,336.5,4.0,23.6,2,0,25,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,
3266,Liew,Carboprost,5281075,negative,0,368.5,2.9,98.0,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
3411,Liew,Diltiazem,39186,positive,1,414.5,3.1,84.4,6,0,29,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,
1419,LIverTox,Miglitol,441314,E,0,207.22,-2.6,104.0,6,5,14,C1C(C(C(C(N1CCO)CO)O)O)O,Nil,
3385,Liew,Dexfenfluramine,66265,positive,0,231.26,3.4,12.0,4,1,16,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,,
1251,LIverTox,Glucosamine,439213,D,1,179.17,-2.8,116.0,6,5,12,C(C1C(C(C(C(O1)O)N)O)O)O,.,
3602,Liew,Isoetharine,3762,negative,0,239.31,1.7,72.7,4,4,17,CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C,,
927,LIverTox,Bictegravir,90311989,E*,0,449.4,2.7,99.2,9,2,32,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,.,
1211,LIverTox,Fluoxetine,3386,C,1,309.33,4.0,21.3,5,1,22,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CYP2D6,
2142,Greene,Hycanthone,3634,HH,1,356.5,2.7,77.9,5,2,25,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,,
201,DILIrank,triptorelin pamoate,25074470,vLess-DILI-Concern,0,1311.4,-0.3,490.0,15,17,95,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,.,oligopeptide
1952,Greene,Bromobenzene,7961,HH,1,157.01,3.0,0.0,0,0,7,C1=CC=C(C=C1)Br,.,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2084,Greene,Erythromycin estolate (1),12560,HH,1,733.9,2.7,194.0,14,5,51,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,.,
3590,Liew,Iloprost,5311181,positive,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
3802,Liew,Oxymorphone,5284604,negative,0,301.34,0.8,70.0,5,2,22,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,CYP3A4,
1103,LIverTox,Disopyramide,3114,B,1,339.5,3.2,59.2,3,1,25,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,CYP3A4,
2716,Xu,Methoxamine HCl,6082,Negative,0,211.26,0.5,64.7,4,2,15,CC(C(C1=C(C=CC(=C1)OC)OC)O)N,.,
1907,Greene,ammonium chloride,25517,NE,0,53.49,,1.0,1,1,2,[NH4+].[Cl-],.,
4075,Liew,Tropicamide,5593,negative,0,284.35,1.5,53.4,3,1,21,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,,
2797,Xu,Sorbitol,5780,Negative,0,182.17,-3.1,121.0,6,6,12,C(C(C(C(C(CO)O)O)O)O)O,.,
598,DILIrank,hydroxyzine,3658,vNo-DILI-Concern,0,374.9,3.7,35.9,4,1,26,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Liver,
210,DILIrank,pramlintide,16132446,vNo-DILI-Concern,0,3951.0,-16.7,1690.0,59,58,277,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CS)NC(=O)C(CCCCN)N,Renal,
3276,Liew,Cefamandole,456255,positive,0,462.5,-0.9,201.0,10,3,31,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,,
1677,LIverTox,Saxagliptin,11243969,E*,0,315.4,0.7,90.4,4,2,23,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,"CYP3A4, CYP3A5",
1657,LIverTox,Rivaroxaban,6433119,A,1,435.9,2.5,116.0,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
3617,Liew,Ketorolac,3826,positive,1,255.27,1.9,59.3,3,1,19,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,
3577,Liew,Histrelin,25077993,negative,0,1323.5,0.7,449.0,15,15,96,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
3375,Liew,Delavirdine,5625,positive,0,456.6,2.4,119.0,7,3,32,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,,
1618,LIverTox,Quercetin,5280343,E,0,302.23,1.5,127.0,7,5,22,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,.,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
1011,LIverTox,Cilostazol,2754,E,0,369.5,3.1,81.9,5,1,27,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,"CYP3A4 ,CYP2C19",
3495,Liew,Fenretinide,5288209,positive,0,391.5,7.3,49.3,2,2,29,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,,
2209,Greene,Methotrexate,126941,HH,1,454.4,-1.8,211.0,12,5,33,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,	Liver and intracellular,
1361,LIverTox,Lixisenatide,90472060,E,0,4858.0,-30.8,2090.0,77,70,342,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,.,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
1026,LIverTox,Clonazepam,2802,D,1,315.71,2.4,87.3,4,1,22,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,CYP3A,
3531,Liew,Formestane,11273,negative,0,302.4,2.6,54.4,3,1,22,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,,
1556,LIverTox,Phentermine,4771,E,0,149.23,1.9,26.0,1,1,11,CC(C)(CC1=CC=CC=C1)N,Liver,
3559,Liew,Glutethimide,3487,negative,0,217.26,1.9,46.2,2,1,16,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,
2627,Xu,Diphenhydramine HCl,3100,Negative,0,255.35,3.3,12.5,2,0,19,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,"	CYP2D6, others",
1711,LIverTox,Sotalol,5253,E,0,272.37,0.2,86.8,5,3,18,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Not metabolized,
3755,Liew,Nepafenac,151075,negative,0,254.28,1.9,86.2,3,2,19,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,,
1050,LIverTox,Cyproheptadine,2913,C,1,287.4,4.7,3.2,1,0,22,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CYP3A4,
2236,Greene,N-acetyl cysteine,12035,NE,0,163.2,0.4,67.4,4,3,10,CC(=O)NC(CS)C(=O)O,Liver,
1709,LIverTox,Sonidegib,24775005,E*,0,485.5,5.8,63.7,8,1,35,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,CYP3A,
873,LIverTox,Apremilast,11561674,E,0,460.5,1.8,128.0,7,1,32,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,"CYP3A4, with minor contributions from CYP2A6, CYP1A2",
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
1576,LIverTox,Plicamycin,5284610,A[HD],1,1085.1,0.6,358.0,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
4056,Liew,Trichlormethiazide,5560,negative,0,380.7,0.6,135.0,7,3,20,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,,
1409,LIverTox,Methylphenidate,4158,C[H],1,233.31,0.2,38.3,3,1,17,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Liver 80% mostly CES1A1-mediated,
1037,LIverTox,Colestipol,62816,E,0,281.83,,101.0,6,5,18,C1C(O1)CCl.C(CNCCNCCNCCN)N,.,
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
3742,Liew,Naftifine,47641,negative,0,287.4,5.1,3.2,1,0,22,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32,,
227,DILIrank,doxapram,3156,vNo-DILI-Concern,0,378.5,3.3,32.8,3,0,28,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,.,
466,DILIrank,cefazolin,33255,vLess-DILI-Concern,1,454.5,-0.4,235.0,12,2,29,CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,.,
2172,Greene,Lactose,6134,NE,0,342.3,-4.7,190.0,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
3735,Liew,Moxifloxacin,152946,positive,1,401.4,0.6,82.1,8,2,29,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,,
2537,Xu,Biotin,171548,Negative,0,244.31,0.3,104.0,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
3896,Liew,Propyliodone,4949,negative,0,447.01,2.4,46.6,4,0,16,CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I,,
2090,Greene,ethinyl estradiol,5991,HH,1,296.4,3.7,40.5,2,2,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,	Liver primarily CYP3A4,
267,DILIrank,regadenoson,219024,vNo-DILI-Concern,0,390.35,-1.5,187.0,10,5,28,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,.,
1131,LIverTox,Edaravone,4021,E,0,174.2,1.3,32.7,2,0,13,CC1=NN(C(=O)C1)C2=CC=CC=C2,.,
1452,LIverTox,Naloxegol,56959087,E,0,651.8,-1.0,127.0,12,2,46,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,CYP3A,
3553,Liew,Gefitinib,123631,positive,1,446.9,4.1,68.7,8,1,31,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,,
511,DILIrank,paliperidone,115237,vNo-DILI-Concern,0,426.5,2.2,82.2,7,1,31,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,.,
3337,Liew,Clofibrate,2796,positive,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
3555,Liew,Gemfibrozil,3463,positive,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
1430,LIverTox,Mitotane,4211,E*,0,320.0,6.2,0.0,0,0,18,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,.,
3062,Liew,Pemetrexed,135410875,positive,1,427.4,0.2,187.0,7,6,31,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,,
1852,LIverTox,Vortioxetine,9966051,E*,0,298.4,4.2,40.6,3,1,21,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,"Liver, primarily CYP2D6-mediated oxidation",
2528,Xu,Bambuterol,54766,Negative,0,367.4,1.2,91.3,6,2,26,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,Extensive Liver.Further metabolized to terbutaline by plasma cholinesterase,
785,LIverTox,Abemaciclib,46220502,E*,0,506.6,3.8,75.0,9,1,37,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,.,
1341,LIverTox,Larotrectinib,46188928,E*,0,428.4,1.7,86.0,7,2,31,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,.,
18,DILIrank,tetracycline,54685734,vLess-DILI-Concern,1,444.4,-2.0,182.0,9,6,32,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,Not metabolized,
3198,Liew,Aprindine,2218,positive,0,322.5,5.2,6.5,2,0,24,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3,,
1343,LIverTox,Lefamulin,25185057,E,0,507.7,4.3,135.0,7,3,35,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,.,
636,DILIrank,nilutamide,4493,vMost-DILI-Concern,1,317.22,2.0,95.2,7,1,22,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,"Liver CYP2C19, FMOTooltip flavin-containing monooxygenase",
1224,LIverTox,Fosphenytoin,56339,A,1,362.27,0.6,116.0,6,3,25,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Liver,
3328,Liew,Clarithromycin,84029,positive,1,748.0,3.2,183.0,14,4,52,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,,
2410,Greene,Ribavirin,37542,E*,0,244.2,-1.8,144.0,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
1022,LIverTox,Clofazimine,2794,E,0,473.4,7.1,40.0,4,1,33,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,.,
3909,Liew,Quinethazone,6307,positive,0,289.74,1.2,110.0,5,3,18,CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl,,
1563,LIverTox,Pimavanserin,10071196,E,0,427.6,4.5,44.8,4,1,31,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,"CYP3A4, CYP3A5, CYP2J2",
1936,Greene,Beclomethasone Dipropionate,21700,NE,0,521.0,3.0,107.0,7,1,36,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,	By esterase enzymes found in most tissues,
272,DILIrank,etravirine,193962,vMost-DILI-Concern,1,435.3,4.5,121.0,7,2,28,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,"CYP3A4,CYP2C9,CYP2C19",
1545,LIverTox,Peramivir,151164,E,0,328.41,0.0,151.0,5,5,23,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,.,
3169,Liew,Amdinocillin,36273,positive,0,325.4,2.1,98.5,5,1,22,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,,
4024,Liew,Thiopental,3000714,positive,0,264.32,,96.6,3,1,17,CCCC(C)C1(C(=O)NC(=S)N=C1[O-])CC.[Na+],Liver,
3436,Liew,Droloxifene,3033767,positive,0,387.5,6.8,32.7,3,1,29,CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3,,
958,LIverTox,Cabazitaxel,9854073,E*,0,835.9,2.7,202.0,14,3,60,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,.,
3366,Liew,Dapiprazole,3033538,negative,0,325.5,2.4,37.2,4,0,24,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,,
60,DILIrank,labetalol,3869,vMost-DILI-Concern,1,328.4,3.1,95.6,4,4,24,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,"Liver pass metabolism,",
3378,Liew,Deserpidine,8550,negative,0,578.7,4.1,109.0,9,1,42,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,,
1353,LIverTox,Levofloxacin,149096,A,1,361.4,-0.4,73.3,8,1,26,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,<5% desmethyl and N-oxide metabolites,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
4080,Liew,Unoprostone,5311236,negative,0,382.5,3.7,94.8,5,3,27,CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O,,
3458,Liew,Erlotinib,176870,positive,1,393.4,3.3,74.7,7,1,29,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,,
3645,Liew,Lonidamine,39562,positive,0,321.2,4.3,55.1,3,1,21,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,,
2261,Greene,Orphenadrine Citrate,4601,NE,0,269.4,3.8,12.5,2,0,20,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,	Liver demethylation,
171,DILIrank,protirelin,638678,vNo-DILI-Concern,0,362.38,-2.5,150.0,5,4,26,C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N,.,
1034,LIverTox,Codeine,5284371,E,0,299.4,1.1,41.9,4,1,22,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,"Liver: CYP2D6 to morphine, CYP3A4 to norcodeine, UGT2B7 to 3- and 6-glucuronides of codeine, norcodeine, and morphine",
1581,LIverTox,Pramipexole,119570,E,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,227.09,1.6,165.0,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
213,DILIrank,albendazole,2082,vMost-DILI-Concern,1,265.33,2.9,92.3,4,2,18,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Liver,
1685,LIverTox,Selexipag,9913767,E,0,496.6,3.8,110.0,7,1,35,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,"Activation by carboxylesterases, inactivation by CYP2C8 and others",
3287,Liew,Cefotiam,43708,positive,1,525.6,-2.4,251.0,13,3,34,CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O,,
3954,Liew,Sertaconazole,65863,positive,0,437.8,6.3,55.3,3,0,27,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,,
3394,Liew,Diacerein,26248,positive,1,368.3,1.9,124.0,8,1,27,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
3650,Liew,Loteprednol,444025,negative,0,466.9,3.9,99.1,7,1,32,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,,
3125,Liew,Valganciclovir,135413535,negative,1,354.36,-1.5,167.0,8,4,25,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,,
3785,Liew,Opipramol,9417,positive,1,363.5,3.6,30.0,4,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,CYP2D6,
2180,Greene,Lidocaine,3676,NE,0,234.34,2.3,32.3,2,1,17,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,"	Liver, 90% CYP3A4",
2507,Xu,Amantadine HCl,64150,Negative,0,187.71,,26.0,1,2,12,C1C2CC3CC1CC(C2)(C3)N.Cl,	Minimal mostly to acetyl metabolites,
3468,Liew,Eszopiclone,969472,negative,0,388.8,0.5,91.8,7,0,27,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,
3382,Liew,Desonide,12536,negative,0,416.5,2.7,93.1,6,2,30,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,,
3857,Liew,Pirbuterol,4845,negative,0,240.3,-0.1,85.6,5,4,17,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,,
3867,Liew,Prajmaline,37042,positive,0,369.5,2.7,43.7,3,2,27,CCC[N+]12C3CC(C(C1O)CC)C4C2CC5(C3N(C6=CC=CC=C65)C)C4O,,
3402,Liew,Diethylpropion,7029,negative,0,205.3,2.8,20.3,2,0,15,CCN(CC)C(C)C(=O)C1=CC=CC=C1,,
1014,LIverTox,Cisplatin,2767,C,1,298.03,,2.0,2,2,5,[NH2-].[NH2-].Cl[Pt+2]Cl,.,
3480,Liew,Etonogestrel,21729469,positive,0,324.5,3.3,37.3,2,1,24,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,,
3511,Liew,Flumethasone,16490,negative,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
760,DILIrank,apomorphine,6005,vNo-DILI-Concern,0,267.32,2.3,43.7,3,2,20,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,"Liver, phase II",
2072,Greene,Dopamine,681,NE,0,153.18,-1.0,66.5,3,3,11,C1=CC(=C(C=C1CCN)O)O,"MAO, COMT",
3980,Liew,Sulfamethizole,5328,positive,1,270.3,0.5,135.0,7,2,17,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,
217,DILIrank,atropine,174174,vNo-DILI-Concern,0,289.4,1.8,49.8,4,1,21,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,???50% hydrolysed to tropine and tropic acid,
2164,Greene,Isoxicam,54677972,NE,0,335.34,3.0,121.0,7,2,23,CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,.,
3288,Liew,Cefpirome,6917674,positive,0,514.6,0.9,208.0,10,2,35,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],,
56,DILIrank,imatinib,5291,vMost-DILI-Concern,1,493.6,3.5,86.3,7,2,37,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,
3823,Liew,Penicillin v,6869,positive,0,350.4,2.1,121.0,6,2,24,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,,
3518,Liew,Fluorometholone,9878,negative,0,376.5,2.0,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
765,DILIrank,norethindrone acetate,5832,vNo-DILI-Concern,0,340.5,3.5,43.4,3,0,25,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,.,
3270,Liew,Carprofen,2581,positive,1,273.71,4.0,53.1,2,2,19,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,,
3510,Liew,Flumequine,3374,positive,1,261.25,2.9,57.6,5,1,19,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,,
1773,LIverTox,Ticarcillin,36921,D,1,384.4,0.8,178.0,8,3,25,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,.,
3852,Liew,Pipecuronium,65332,negative,0,762.7,,59.1,8,0,45,CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-],,
497,DILIrank,clometacin,33176,vMost-DILI-Concern,1,357.8,4.0,68.5,4,1,25,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,.,
3634,Liew,Levocabastine,54385,negative,0,420.5,2.5,64.3,5,1,31,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,,
3333,Liew,Clobetasol,5311051,negative,0,410.9,2.5,74.6,5,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,,
2665,Xu,Gallamine Triethiodide,6172,Negative,0,891.5,,27.7,6,0,39,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],.,
3147,Liew,Alacepril,71992,positive,0,406.5,2.1,129.0,6,2,28,CC(CSC(=O)C)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O,,
3669,Liew,Memantine,4054,positive,1,179.3,3.3,26.0,1,1,13,CC12CC3CC(C1)(CC(C3)(C2)N)C,,
3476,Liew,Etidocaine,37497,negative,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
3868,Liew,Pranlukast,4887,positive,0,481.5,4.2,119.0,7,2,36,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,CYP3A4,
3939,Liew,Rofecoxib,5090,positive,1,314.4,2.3,68.8,4,0,22,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Liver,
4061,Liew,Trihexyphenidyl,5572,negative,0,301.5,4.5,23.5,2,1,22,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,,
1661,LIverTox,Rolapitant,10311306,E,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
3913,Liew,Raltitrexed,104758,positive,0,458.5,1.4,177.0,8,4,32,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,,
3194,Liew,Anisotropine,6647,negative,0,362.3,,26.3,3,0,21,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],,
3880,Liew,Procainamide,4913,positive,1,235.33,0.9,58.4,3,2,17,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,CYP2D6,
3812,Liew,Paromomycin,441375,negative,1,713.7,,430.0,23,15,47,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,
2240,Greene,Nalidixic Acid,4421,HH,1,232.23,1.4,70.5,5,1,17,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,	Partially Liver,
147,DILIrank,benzbromarone,2333,vMost-DILI-Concern,1,424.1,5.7,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,.,
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
461,DILIrank,adefovir,60172,vLess-DILI-Concern,0,273.19,-2.0,136.0,8,3,18,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,.,
2822,Xu,Trimethadione,5576,Positive,1,143.14,0.3,46.6,3,0,10,CC1(C(=O)N(C(=O)O1)C)C,	Demethylated to dimethadione,
3280,Liew,Cefmenoxime,9570757,positive,0,511.6,0.0,270.0,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
3310,Liew,Chloroxine,2722,negative,0,214.04,3.5,33.1,2,1,13,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,,
4065,Liew,Trimethobenzamide,5577,positive,1,388.5,2.3,69.3,6,1,28,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,
2625,Xu,Digoxin,2724385,Negative,0,780.9,1.3,203.0,14,6,55,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Liver 16%,
1577,LIverTox,Pomalidomide,134780,D,1,273.24,0.2,110.0,5,2,20,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Liver mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6,
2832,Xu,Vidarabine,21704,Negative,0,267.24,-1.1,140.0,8,4,19,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
1573,LIverTox,Plazomicin,42613186,E,0,592.7,-6.2,269.0,15,11,41,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,.,
3387,Liew,Dexlansoprazole,9578005,positive,1,369.4,2.8,87.1,8,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,,
140,DILIrank,primidone,4909,vNo-DILI-Concern,0,218.25,0.9,58.2,2,2,16,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Liver,
452,DILIrank,gadobenate dimeglumine,105124,vNo-DILI-Concern,0,667.7,,220.0,14,2,37,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],.,
278,DILIrank,prasugrel hydrochloride,6918456,vLess-DILI-Concern,1,373.4,3.6,74.8,6,0,26,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,.,
959,LIverTox,Cabozantinib,25102847,E*,0,501.5,5.4,98.8,7,2,37,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,CYP3A4,
1851,LIverTox,Vorinostat,5311,E,0,264.32,1.9,78.4,3,3,19,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Liver glucuronidation and ??-oxidation
CYP system not involved",
1732,LIverTox,Suvorexant,24965990,E,0,450.9,4.9,80.3,6,0,32,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,"Liver CYP3A major, CYP2C19 minor",
2677,Xu,Idarubicin HCl,42890,Negative,0,497.5,1.9,177.0,10,5,36,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,
3166,Liew,Ambenonium,2131,negative,0,537.6,5.1,58.2,2,2,36,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,,
1367,LIverTox,Loratadine,3957,E*,0,382.9,5.2,42.4,3,0,27,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,"CYP2D6, CYP3A4",
902,LIverTox,Baloxavir,124081896,E,0,571.6,3.8,123.0,12,0,40,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,.,
3483,Liew,Etretinate,5282375,positive,0,354.5,6.8,35.5,3,0,26,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,,
922,LIverTox,Betrixaban,10275777,E*,0,451.9,3.6,107.0,5,3,32,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,.,
3512,Liew,Flunarizine,941361,negative,0,404.5,6.0,6.5,4,0,30,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
1185,LIverTox,Ezogabine,121892,E,0,303.33,2.8,76.4,5,3,22,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,Liver glucuronidation and acetylation. CYP not involved,
3756,Liew,Netilmicin,41859,positive,0,475.6,-4.2,200.0,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
3485,Liew,Exisulind,5472495,positive,0,372.4,3.5,79.8,5,1,26,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,,
956,LIverTox,Butorphanol,5361092,ND,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
1435,LIverTox,Molindone,23897,D,1,276.37,1.7,45.3,3,1,20,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Liver,
3192,Liew,Aniracetam,2196,negative,0,219.24,1.6,46.6,3,0,16,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,,
3218,Liew,Balsalazide,5362070,negative,0,357.32,1.2,145.0,8,4,26,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,,
1428,LIverTox,Mirtazapine,4205,C,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
3487,Liew,Famciclovir,3324,positive,0,321.33,0.0,122.0,8,1,23,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,,
2764,Xu,Pinacidil,4826,Negative,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
836,LIverTox,Ampicillin,6249,C,1,349.4,-1.1,138.0,6,3,24,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,12 to 50%,
3888,Liew,Promethazine,4927,positive,0,284.4,4.8,31.8,3,0,20,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Liver,
2243,Greene,naproxen,156391,WE,1,230.26,3.3,46.5,3,1,17,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,	Liver to 6-desmethylnaproxen,
3273,Liew,Caspofungin,468682,positive,1,1093.3,0.3,412.0,18,16,77,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,,
291,DILIrank,alclofenac,30951,vMost-DILI-Concern,1,226.65,2.5,46.5,3,1,15,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,.,
4001,Liew,Temocillin,171758,negative,0,414.5,1.1,187.0,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,581.6,-8.0,336.0,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
3526,Liew,Fluticasone,5311101,negative,0,444.5,3.2,99.9,8,2,30,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,,
606,DILIrank,l-carnitine,288,vNo-DILI-Concern,0,161.2,-0.2,60.4,3,1,11,C[N+](C)(C)CC(CC(=O)[O-])O,slightly,
3841,Liew,Phenoxybenzamine,4768,negative,0,303.8,4.4,12.5,2,0,21,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,,
1290,LIverTox,Ibrutinib,24821094,D,1,440.5,3.6,99.2,6,1,33,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,"CYP3A,CYP2D6",
1509,LIverTox,Osimertinib,71496458,E*,0,499.6,3.7,87.6,7,2,37,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,Oxidation CYP3A,
1557,LIverTox,Phentermine-Topiramate,56842108,E*,0,488.6,,150.0,10,2,33,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N,.,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
1527,LIverTox,Pasireotide,9941444,E*,0,1047.2,4.7,281.0,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
601,DILIrank,l-methionine,6137,vNo-DILI-Concern,0,149.21,-1.9,88.6,4,2,9,CSCCC(C(=O)O)N,.,
4017,Liew,Tetrahydrozoline,5419,negative,0,200.28,1.8,24.4,1,1,15,C1CC(C2=CC=CC=C2C1)C3=NCCN3,,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
574,DILIrank,fludarabine,657237,vNo-DILI-Concern,0,285.23,-0.6,140.0,9,4,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,.,
1707,LIverTox,Sofosbuvir,45375808,A,1,529.5,1.0,153.0,11,3,36,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,"Quickly activated to triphosphate CatA/CES1, HIST1, phosphorylation",
107,DILIrank,prednisone,5865,vLess-DILI-Concern,1,358.4,1.5,91.7,5,2,26,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,prednisolone liver,
3629,Liew,Letrozole,3902,positive,1,285.3,2.7,78.3,4,0,22,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,,
3842,Liew,Phenprocoumon,9908,negative,0,280.3,3.6,46.5,3,1,21,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,"CYP2C9, CYP3A4",
1712,LIverTox,Spironolactone,5833,D,1,416.6,2.9,85.7,5,0,29,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,"Liver, others: Deacetylation via CESTooltip carboxylesterase  S-Oxygenation via FOMTooltip flavin-containing monooxygenase S-Methylation via TMTTooltip thiol S-methyltransferase Dethioacetylation Hydroxylation via CYP3A4  Lactone hydrolysis via PON3",
2057,Greene,Dimercaprol,3080,HH,0,124.23,0.2,22.2,3,3,6,C(C(CS)S)O,,
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
3733,Liew,Morniflumate,72106,negative,0,395.4,3.7,63.7,9,1,28,C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F,,
2750,Xu,Paroxetine,43815,Negative,1,329.4,3.5,39.7,5,1,24,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,"Extensive, liver mostly CYP2D6-mediated",
897,LIverTox,Azilsartan,135415867,E*,1,456.4,4.4,115.0,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
4022,Liew,Thiethylperazine,5440,positive,0,399.6,5.4,60.3,5,0,27,CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C,,
657,DILIrank,pimozide,16362,vNo-DILI-Concern,0,461.5,6.3,35.6,4,1,34,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,"CYP3A4, CYP1A2,CYP2D6",
118,DILIrank,isoproterenol,3779,vNo-DILI-Concern,0,211.26,-0.6,72.7,4,4,15,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,.,
3470,Liew,Ethacrynic acid,3278,positive,1,303.13,3.8,63.6,4,1,19,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,,
3434,Liew,Doxycycline,54671203,positive,1,444.4,-0.7,182.0,9,6,32,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,,
380,DILIrank,calcium acetate,6116,vNo-DILI-Concern,0,158.17,,80.3,4,0,9,CC(=O)[O-].CC(=O)[O-].[Ca+2],.,
3825,Liew,Pentazocine,441278,negative,0,285.4,3.3,23.5,2,1,21,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,Liver,
1299,LIverTox,Indinavir,5362440,C,1,613.8,2.8,118.0,7,4,45,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,CYP3A4,
1749,LIverTox,Temazepam,5391,E,0,300.74,2.2,52.9,3,1,21,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Liver,
3138,Liew,Acemetacin,1981,positive,0,415.8,4.2,94.8,6,1,29,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,,
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
3191,Liew,Anastrozole,2187,positive,1,293.4,2.1,78.3,4,0,22,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,
3235,Liew,Bethanidine,2368,negative,0,177.25,0.9,36.4,1,2,13,CNC(=NC)NCC1=CC=CC=C1,,
3760,Liew,Niclosamide,4477,negative,0,327.12,4.0,95.2,4,2,21,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,
1378,LIverTox,Macitentan,16004692,E*,0,588.3,3.7,137.0,10,2,32,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,"Hydrolysis, oxidation CYP3A4",
1113,LIverTox,Doxazosin,3157,E*,0,451.5,2.5,112.0,9,1,33,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Liver,
3750,Liew,Nedocromil,50294,negative,0,371.3,2.2,121.0,8,2,27,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,,
3517,Liew,Fluoroacetic acid,5237,positive,0,78.04,0.2,37.3,3,1,5,C(C(=O)O)F,,
2718,Xu,Methysergide Maleate,9681,Negative,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
3101,Liew,Teriparatide,16132393,negative,0,4118.0,-18.7,1800.0,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
1221,LIverTox,Foscarnet,3415,D,1,126.01,-2.0,94.8,5,3,7,C(=O)(O)P(=O)(O)O,.,
3210,Liew,Azatadine,19861,negative,0,290.4,3.6,16.1,2,0,22,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1,,
3472,Liew,Ethchlorvynol,5281077,positive,0,144.6,1.5,20.2,1,1,9,CCC(C=CCl)(C#C)O,,
132,DILIrank,glipizide,3478,vLess-DILI-Concern,1,445.5,1.9,139.0,6,3,31,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Liver hydroxylation,
3414,Liew,Dinoprostone,5280360,positive,0,352.5,2.8,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,,
424,DILIrank,almotriptan,123606,vNo-DILI-Concern,0,335.5,1.6,64.8,4,1,23,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,	Liver,
4084,Liew,Valrubicin,454216,negative,0,723.6,4.0,215.0,16,5,51,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,
3600,Liew,Isepamicin,3037209,positive,0,569.6,-6.9,298.0,16,12,39,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O,,
489,DILIrank,conivaptan,151171,vNo-DILI-Concern,0,498.6,5.7,78.1,3,2,38,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,.,
3887,Liew,Promazine,4926,positive,0,284.4,4.5,31.8,3,0,20,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,,
3224,Liew,Benoxinate,4633,negative,0,308.4,3.1,64.8,5,1,22,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,,
>>>>>>> 772863a274eb6a0a836c8f6db049ba9b99d86e02
